Commission renews Nordion (Canada) Inc.'s Class IB nuclear substance processing facility licence for a period of 25 years

September 2, 2025 – Ottawa

Today, the Canadian Nuclear Safety Commission (CNSC) announced the Commission’s decision to renew the Class IB nuclear substance processing facility operating licence issued to Nordion (Canada) Inc. (Nordion) for a period of 25 years. The Nordion facility is located at 447 March Road, Ottawa, Ontario, on the traditional unceded territory of the Algonquin Anishnaabeg peoples.

In making its decision, the Commission considered submissions from Nordion, CNSC staff and 10 intervenors during a public hearing. The Commission concluded that Nordion remains qualified to carry on the activities that the renewed licence will authorize. The decision includes a requirement for Nordion to provide a comprehensive performance update to the Commission on the conduct of its licensed activities every 8 years of the licence period; i.e., in 2033 and 2041. There are no changes to Nordion’s licensed activities under the renewed licence.

The record of decision is available upon request to the Commission Registry at interventions@cnsc-ccsn.gc.ca. The decision will also be posted in both official languages on the CNSC website at cnsc-ccsn.gc.ca at a later date. All submissions are available on the CNSC website.

The CNSC regulates the use of nuclear energy and materials to protect health, safety, security and the environment; to implement Canada’s international commitments on the peaceful use of nuclear energy; and to disseminate objective scientific, technical and regulatory information to the public. The Commission is a quasi-judicial administrative tribunal set up at arm’s length from government, independent from any political, government or private sector influence.